NCT01727622View on ClinicalTrials.gov

Arterial Spin Labeling (ASL) MRI for Cognitive Decline

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 11, 2018

Study Completion Date

May 31, 2018

Conditions
Mild Cognitive ImpairmentAlzheimer's Disease
Interventions
DRUG

FDG-PET

Diagnostic: FDG-PET imaging to examine neuronal health

OTHER

ASL-MRI

Arterial-Spin Labeled MRI to examine cerebral blood flow

PROCEDURE

Lumbar Puncture

Lumbar puncture to acquire a small amount of cerebrospinal fluid for protein level analyses. Note that this will not be required in all participants.

Trial Locations (1)

19104

Penn Memory Center, Philadelphia

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Pennsylvania

OTHER

NCT01727622 - Arterial Spin Labeling (ASL) MRI for Cognitive Decline | Biotech Hunter | Biotech Hunter